(Q39505837)

12 September 2017

1 reference

title

Adverse reactions with angiotensin converting enzyme (ACE) inhibitors (English)

1 reference

12 September 2017

DiBianco R

1

1 reference

12 September 2017

1 March 1986

1 reference

12 September 2017

1 reference

12 September 2017

1

1 reference

12 September 2017

122-141

1 reference

12 September 2017

2

1 reference

Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure

12 September 2017

1 reference

12 December 2020

Successful reintroduction of captopril following neutropenia

1 reference

12 December 2020

Captopril-induced acute renal artery thrombosis and persistent anuria in a patient with documented pre-existing renal artery stenosis and renal failure

1 reference

12 December 2020

1 reference

12 December 2020

Renal response to angiotensin-converting enzyme inhibition

1 reference

12 December 2020

Captopril-Induced Acute Reversible Renal Failure

1 reference

12 December 2020

Captopril during pregnancy

1 reference

12 December 2020

Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor mk 421 (enalapril) in captopril-intolerant patients

1 reference

12 December 2020

Acute electrocardiographic effects of captopril in the initial treatment of malignant or severe hypertension

1 reference

12 December 2020

Reversible captopril-associated bone marrow aplasia

1 reference

12 December 2020

Comparison of antihypertensive effects of captopril and propranolol in essential hypertension

1 reference

12 December 2020

Medical intelligence drug therapy: captopril

1 reference

12 December 2020

Reversible acute on chronic renal failure during captopril treatment.

1 reference

12 December 2020

Reversible cholestatic jaundice and hyperamylasaemia associated with captopril treatment

1 reference

12 December 2020

Captopril associated granulocytopenia in hypertension after renal transplantation

1 reference

12 December 2020

Captopril induced reversible renal failure: a marker of renal artery stenosis affecting a solitary kidney

1 reference

12 December 2020

Determinants of clinical response and survival in patients with congestive heart failure treated with captopril

1 reference

12 December 2020

Reduction of the antihypertensive effect of captopril induced by prostaglandin synthetase inhibition

1 reference

12 December 2020

Combined treatment of severe intractable hypertension with captopril and diuretic

1 reference

12 December 2020

Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure

1 reference

12 December 2020

Acute renal failure, skin rash, and eosinophilia associated with captopril therapy

1 reference

12 December 2020

Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors

1 reference

12 December 2020

Repeated renal failure with use of captopril in a cystinotic renal allograft recipient

1 reference

12 December 2020

Captopril and Enalapril

1 reference

12 December 2020

A specific orally active inhibitor of angiotensin-converting enzyme in man.

1 reference

12 December 2020

Transient renal dysfunction during initial inhibition of converting enzyme in congestive heart failure

1 reference

12 December 2020

Nephrotic syndrome from captopril

1 reference

12 December 2020

Review of the Overall Experience of Captopril in Hypertension

1 reference

12 December 2020

Captopril in congestive heart failure: Improved left ventricular function with decreased metabolic cost

1 reference

12 December 2020

Long-term efficacy of captopril in renovascular and essential hypertension

1 reference

12 December 2020

Fatal Pancytopenia Associated with the Use of Captopril

1 reference

12 December 2020

Captopril and renal function

1 reference

12 December 2020

Captopril--indications and clinical problems.

1 reference

12 December 2020

Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment

1 reference

12 December 2020

Reversible renal failure following treatment with captopril and diuretics in patients with renovascular hypertension

1 reference

12 December 2020

1 reference

12 December 2020

Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy

1 reference

12 December 2020

Captopril in the treatment of scleroderma renal crisis

1 reference

12 December 2020

Liver enzymes in hypertension.

1 reference

12 December 2020

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

12 December 2020

"First dose" effect of captopril

1 reference

12 December 2020

Influence of food on acute and chronic effects of captopril in essential hypertensive patients.

1 reference

12 December 2020

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

1 reference

12 December 2020

Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome

1 reference

12 December 2020

Extended use of captopril

1 reference

12 December 2020

Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension

1 reference

12 December 2020

Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluations

1 reference

12 December 2020

Evidence from a dual action of converting enzyme inhibitor on blood pressure in normal man

1 reference

12 December 2020

Splint renal function after captopril in unilateral renal artery stenosis

1 reference

12 December 2020

Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon

1 reference

12 December 2020

Overall tolerance and safety of enalapril

1 reference

12 December 2020

Safety of angiotensin-converting-enzyme inhibitors

1 reference

12 December 2020

Disappearance of captopril-induced taste disturbance after substitution with angiotensin-converting-enzyme inhibitor HOE 498.

1 reference

12 December 2020

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

1 reference

12 December 2020

Captopril: reversible renal failure with severe hyperkalaemia

1 reference

12 December 2020

Reversible reduction in renal function during treatment with captopril

1 reference

12 December 2020

Safety and efficacy of enalapril. Summing up the evidence

1 reference

12 December 2020

Comparative Antihypertensive Effects of Enalapril Maleate and Hydrochlorothiazide, Alone and in Combination

1 reference

12 December 2020

Correction of dilutional hyponatremia in severe chronic heart failure by converting-enzyme inhibition

1 reference

12 December 2020

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Resolution of captopril-induced rash after substitution of enalapril

1 reference

12 December 2020

Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure

1 reference

12 December 2020

Severe reversible azotemia from captopril therapy. Report of three cases and review of the literature

1 reference

12 December 2020

Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension

1 reference

12 December 2020

Captopril-Induced Membranous Glomerulopathy

1 reference

12 December 2020

Successful low dose captopril rechallenge following drug-induced leucopenia

1 reference

12 December 2020

Captopril-associated cholestatic jaundice

1 reference

12 December 2020

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

1 reference

12 December 2020

Captopril-associated agranulocytosis

1 reference

12 December 2020

Enalapril, a rash, and captopril

1 reference

12 December 2020

Possible risk with captopril in pregnancy: some animal data

1 reference

12 December 2020

Captopril administration in pregnancy impairs fetal angiotensin converting enzyme activity and neonatal adaptation

1 reference

12 December 2020

Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake.

1 reference

12 December 2020

1 reference

12 December 2020

Impairment of captopril bioavailability by concomitant food and antacid intake

1 reference

12 December 2020

Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension

1 reference

12 December 2020

Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.

1 reference

12 December 2020

Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril

1 reference

12 December 2020

Renal vasodilation by converting enzyme inhibition. Role of renal prostaglandins.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

1 reference

12 December 2020

Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors: past, present, and bright future

1 reference

12 December 2020

Captopril-induced eruptions

1 reference

12 December 2020

Fatal bone-marrow suppression associated with captopril

1 reference

12 December 2020

Nonoliguric acute renal failure after captopril therapy

1 reference

12 December 2020

Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary Kidney

1 reference

12 December 2020

Captopril-associated neutropenia. Who is at risk?

1 reference

12 December 2020

Angiotensin converting enzyme (ACE) inhibitors

1 reference

12 December 2020

The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation

1 reference

12 December 2020

Alopecia associated with captopril treatment

1 reference

12 December 2020

Fatal Stevens-Johnson syndrome in a patient on captopril and allopurinol

1 reference

12 December 2020

Renal involvement in progressive systemic sclerosis: Prolonged survival with aggressive antihypertensive management

1 reference

12 December 2020

Renal Failure Associated With Captopril

1 reference

12 December 2020

Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension

1 reference

12 December 2020

Treatment of hypertension with angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Effect of captopril on blood pressure and renal function in patients with transplant renal artery stenosis

1 reference

12 December 2020

Proteinuria and abnormalities of the renal glomerulus in patients with hypertension

1 reference

12 December 2020

Neurological dysfunction in two patients receiving captopril and cimetidine

1 reference

12 December 2020

Repeated renal failure with use of captopril in a cystinotic renal allograft recipient

1 reference

12 December 2020

Transient anuria following administration of angiotensin I-converting enzyme inhibitor (SQ 14225) in a patient with renal artery stenosis of the solitary kidney successfully treated with renal autotransplantation

1 reference

12 December 2020

Hyperkalemia resulting from captopril administration

1 reference

12 December 2020

Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Cough associated with the use of captopril

1 reference

12 December 2020

Nephrotic syndrome during captopril therapy

1 reference

12 December 2020

Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition

1 reference

12 December 2020

Captopril and resistant ascites: a word of caution

1 reference

12 December 2020

Development of antinuclear antibody in patients treated with high doses of captopril

1 reference

12 December 2020

Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group

1 reference

12 December 2020

Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure

1 reference

12 December 2020

Does captopril cause renal damage in hypertensive patients? Report from the Captopril Collaborative Study Group

1 reference

12 December 2020

Captopril and resistant ascites

1 reference

12 December 2020

Treatment of patients with severe hypertension by inhibition of angiotensin-converting enzyme

1 reference

12 December 2020

Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril

1 reference

12 December 2020

Side-effects of captopril

1 reference

12 December 2020

Membranous glomerulopathy associated with captopril therapy

1 reference

12 December 2020

Taste loss associated with captopril treatment

1 reference

12 December 2020

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

1 reference

12 December 2020

Cough and wheeze caused by inhibitors of angiotensin-converting enzyme

1 reference

12 December 2020

Erosions and ulcers of the mouth

1 reference

12 December 2020

Captopril-induced agranulocytosis in systemic sclerosis

1 reference

12 December 2020

Converting enzyme inhibition with an orally active compound in hypertensive man

1 reference

12 December 2020

Improvement of chronic congestive heart-failure by oral captopril

1 reference

12 December 2020

Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881.

1 reference

12 December 2020

Captopril in the treatment of clinical hypertension and cardiac failure

1 reference

12 December 2020

Effect of vasodilators on survival in chronic congestive heart failure

1 reference

12 December 2020

Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure

1 reference

12 December 2020

Hemolytic anemia: possible complication of captopril therapy

1 reference

12 December 2020

Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent

1 reference

12 December 2020

Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure.

1 reference

12 December 2020

Reversal of captopril-induced psychosis with naloxone

1 reference

12 December 2020

Captopril-induced renal insufficiency and the role of sodium balance

1 reference

12 December 2020

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

1 reference

12 December 2020

Enalapril treatment in a patient with impaired renal function and intolerance to captopril

1 reference

12 December 2020

Captopril-associated granulocytopenia in hypertension after renal transplantation

1 reference

12 December 2020

Worsening of anemia induced by long-term use of captopril in hemodialysis patients

1 reference

12 December 2020

Enalapril Worldwide Experience

1 reference

12 December 2020

Unilateral membranous glomerulopathy during captopril treatment

1 reference

12 December 2020

Effect of food on the bioavailability of captopril in healthy subjects

1 reference

12 December 2020

Hepatitis associated with captopril treatment

1 reference

12 December 2020

SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme

1 reference

12 December 2020

Captopril-associated renal failure with endarteritis but not renal-artery stenosis in transplant recipient

1 reference

12 December 2020

Captopril kinetics in chronic congestive heart failure

1 reference

12 December 2020

Repeated renal failure with captopril

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in renovascular hypertension: failure of the stenotic kidney

1 reference

12 December 2020

Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease

1 reference

12 December 2020

Angiotensin converting enzyme inhibition in patients with congestive heart failure

1 reference

12 December 2020

Captopril and membranous glomerulopathy

1 reference

12 December 2020

Captopril and resistant ascites.

1 reference

12 December 2020

Regional circulatory response to converting-enzyme inhibition in congestive heart failure

1 reference

12 December 2020

Captopril and agranulocytosis

1 reference

12 December 2020

Clinical experience with captopril in the treatment of severe drug-resistant hypertension

1 reference

12 December 2020

The present molecules of converting enzyme inhibitors

1 reference

12 December 2020

Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients

1 reference

12 December 2020

Inhibition of peptidase degrading endogenous opioids: a new trend in the management of migraine and correlated "pain diseases"

1 reference

12 December 2020

Captopril in hypertension; seven years later

1 reference

12 December 2020

Alpha-blockers and converting enzyme inhibitors

1 reference

12 December 2020

Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety

1 reference

12 December 2020

Low-dose captopril: its use in mild to moderate hypertension unresponsive to diuretic treatment

1 reference

12 December 2020

Long-term hemodynamic and clinical efficacy of captopril therapy in ambulatory management of severe chronic congestive heart failure

1 reference

12 December 2020

Autoantibodies during captopril treatment

1 reference

12 December 2020

Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics.

1 reference

12 December 2020

Severe cutaneous reactions to captopril

1 reference

12 December 2020

Enalapril in the treatment of hypertension with renal artery stenosis

1 reference

12 December 2020

Membranous Glomerulopathy and Nephrotic Syndrome After Captopril Therapy

1 reference

12 December 2020

Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report

1 reference

12 December 2020

Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation

1 reference

12 December 2020

Captopril and frusemide in severe drug-resistant hypertension

1 reference

12 December 2020

Fetal abnormality associated with the use of captopril during pregnancy

1 reference

12 December 2020

Immune-complex glomerulopathy in patients treated with captopril

1 reference

12 December 2020

Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia

1 reference

12 December 2020

Angiotensin I converting enzyme activity in hypertension. Relationship to blood pressure, renin-sodium profiles, and antihypertensive therapy

1 reference

12 December 2020

Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies

1 reference

12 December 2020

Renal handling of captopril: effect of probenecid

1 reference

12 December 2020

Hypertension and congestive heart failure: Benefits of converting enzyme inhibition (captopril)

1 reference

12 December 2020

Renal Response to Captopril in Severe Heart Failure: Role of Furosemide in Natriuresis and Reversal of Hyponatremia

1 reference

12 December 2020

Fatal bone-marrow suppression associated with captopril.

1 reference

12 December 2020

Monotherapy of essential hypertension with a converting-enzyme inhibitor

1 reference

12 December 2020

Captopril-induced hyponatremia with irreversible neurologic damage.

1 reference

12 December 2020

Acute changes in blood pressure and vasoactive hormones after captopril in hypertensive patients

1 reference

12 December 2020

Proteinuria during long-term captopril therapy

1 reference

12 December 2020

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

1 reference

12 December 2020

Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosis

1 reference

12 December 2020

A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA

1 reference

12 December 2020

Temporary ageusia related to captopril

1 reference

12 December 2020

Captopril and Renal Autoregulation

1 reference

12 December 2020

Captopril in severe treatment-resistant hypertension

1 reference

12 December 2020

Comparative Studies: Enalapril Versus Hydrochlorothiazide as First-Step Therapy for the Treatment of Primary Hypertension

1 reference

12 December 2020

A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension

1 reference

12 December 2020

Clinical applications of angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

Cutaneous reactions to captopril. Predictive value of skin tests

1 reference

12 December 2020

Severe hyponatremia associated with captopril therapy

1 reference

12 December 2020

Pityriasis rosea-like rash from captopril

1 reference

12 December 2020

Mechanism of deterioration in renal function in patients with renovascular hypertension treated with enalapril

1 reference

12 December 2020

Captopril-associated leucopenia confirmed by rechallenge in patient with renal failure

1 reference

12 December 2020

Influence of food on the clinical effect of angiotensin I converting enzyme inhibitor (SQ 14,225)

1 reference

12 December 2020

Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia

1 reference

12 December 2020

Reversible renal failure during treatment with captopril

1 reference

12 December 2020

Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis

1 reference

12 December 2020

Captopril: five years on.

1 reference

12 December 2020

Identifiers

0 references

1 reference

PubMed ID

3023783